肺癌

     Scientists say a new compound PBOX-15 can kill chronic lymphocytic leukemia (CLL) in patients with cancer cells in vivo, while no effect on healthy cells, research published in the latest issue of "Cancer Research" Journal .

Trinity College Dublin, Ireland and Italy, researchers at the University of Siena in the 55 patients tested on a sample of PBOX-15. Studies have shown that, PBOX-15 can even kill cancer cells in vivo in patients with adult CLL, which cancer cells are resistant to current therapies.

Person in charge of the research team, Trinity College pointed out that medical experts Makeluola, PBOX-15 can interfere with the structure of cancer cells, it activates a mechanism leading to cell death, even though these cells have already produced a resistance to chemotherapy.

Laura said, PBOX-15 in the treatment of CLL has much potential, but is still in early stages of research have yet to be further experiments to observe the means to be used as a treatment will not adversely affected.

CLL CLL for short, is a slow onset of some immune cell lines and malignant lymphocyte dysfunction disease, more common in Caucasians in Europe and America.